Brukinsa 160 MG tablet 60S

Ended Awarded

Contract number
SPE2DB26FWGCP
Awardee
Awarding agency
Obligated
$8,635

Award facts

Contract value 100% obligated
$8,635.33 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
424210 Drugs and Druggists' Sundries Merchant Wholesalers
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Conshohocken, PA 19428, USA

Award details come from SAM.gov/FPDS.

About this award

The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for BRUKINSA 160 mg tablets (60-count units) valued at $8,635.33 under a firm fixed price contract type. The award was made on November 10, 2025, with an ultimate completion date of December 3, 2025. This is a non-set-aside competitive award, with performance to take place at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare systems globally.

AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical procurement vendor headquartered in Conshohocken, Pennsylvania, with an established track record of competitively awarded contracts with the Defense Logistics Agency. The company's federal contract portfolio demonstrates extensive experience supplying brand-name and generic medications, vaccines, and specialized medical commodities across multiple therapeutic domains to support military and veteran healthcare systems. The broader SPE2DX contract vehicle positions AmerisourceBergen to serve the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems, with the DLA planning to expand its Pharmaceutical Prime Vendor Global Program Generation V with multiple regional awards involving multiple contractors.

Quick answers

Who was awarded contract SPE2DB26FWGCP?

SPE2DB26FWGCP was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 10, 2025.

How much is contract SPE2DB26FWGCP worth?

The government has obligated $8,635 on SPE2DB26FWGCP.

Is contract SPE2DB26FWGCP an order under another contract?

Yes. SPE2DB26FWGCP is a delivery order under SPE2DB25D3020, an indefinite delivery contract.

Was contract SPE2DB26FWGCP competed?

The extent of competition for SPE2DB26FWGCP was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award